RCSI University of Medicine and Health Sciences

By Mindo - 02nd Nov 2020 | 114 views

Clinician researchers at RCSI University of Medicine and Health Sciences have developed, for the first time, a score that can accurately predict which patients will develop a severe form of COVID-19. The study was published in The Lancet's translational research journal EBioMedicine this month. The measurement, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions when identifying patients who may benefit from therapies, such as steroids, and admission to intensive care units. Pictured (l-r) is RCSI Professor of Medicine Gerry McElvaney, the study’s senior author with co-author, RCSI Professor of Anaesthesia and Critical Care, Ger Curley. Picture credit: Ray Lohan/ RCSI

Clinician researchers at RCSI University of Medicine and Health Sciences have developed, for the first time, a score that can accurately predict which patients will develop a severe form of Covid-19. The study was published in The Lancet’s translational research journal EBioMedicine last month. The measurement, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions when identifying patients who may benefit from therapies, such as steroids, and admission to intensive care units.

Pictured L-R are: RCSI Professor of Medicine Gerry McElvaney, the study’s senior author, with co-author, RCSI Professor of Anaesthesia and Critical Care Ger Curley

Leave a Reply

Latest
Latest Issue
The Medical Independent 26th September 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read